Recessive mutations in myosin 15, a class XV unconventional myosin, cause profound congenital deafness in humans and both deafness and vestibular dysfunction in mice homozygous for the shaker 2 and shaker 2 J alleles. The shaker 2 allele is a previously described missense mutation of a highly conserved residue in the motor domain of myosin XV. The shaker 2 J lesion, in contrast, is a 14.7 kb deletion that removes the last six exons from the 3'-terminus of the Myo15 transcript. These exons encode a FERM (F, ezrin, radixin and moesin) domain that may interact with integral membrane proteins. Despite the deletion of six exons, Myo15 mRNA transcripts and protein are present in the post-natal day 1 shaker 2 J inner ear, which suggests that the FERM domain is critical for the development of normal hearing and balance. Myo15 transcripts are first detectable at embryonic day 13.5 in wild-type mice. Myo15 transcripts in the mouse inner ear are restricted to the sensory epithelium of the developing cristae ampularis, macula utriculi and macula sacculi of the vestibular system as well as to the developing organ of Corti. Both the shaker 2 and shaker 2 J alleles result in abnormally short hair cell stereocilia in the cochlear and vestibular systems. This suggests that Myo15 may be important for both the structure and function of these sensory epithelia.
INTRODUCTION
The human hereditary deafness locus DFNB3 was mapped to chromosome 17p11.2 in a large kindred from the village of Bengkala, Indonesia (1, 2) . Genes in this region of human chromosome 17p were conserved along a portion of mouse chromosome 11 to which shaker 2 (sh2) had been mapped (2, 3) . Shaker 2 homozygous mice are congenitally deaf and have vestibular defects that cause circling behavior (4, 5) . Myo15, a novel unconventional myosin, was discovered to be the gene responsible for the sh2 phenotype by genetic complementation with a bacterial artificial chromosome (BAC) transgene and DNA sequence analysis (3) . The Myo15 gene is ∼60 kb in length and contains 66 exons (GenBank accession no. AF144093) (6) . The predicted full-length transcript is >12 kb and encodes a 3511 amino acid protein.
Myosins are proteins that bind to actin filaments and function as molecular motors. They produce force by cycling between two conformation states controlled by the binding and hydrolysis of ATP (7) . Myosins form a superfamily of proteins which includes the conventional class II myosins and 14 classes of unconventional myosins which are distinguished based on homology of the motor domains. All myosins share a common structural organization. The motor domain contains the actin-and ATP-binding sites followed by a flexible neck region that contains myosin light chain-binding sites. The Cterminal portion of a myosin protein forms a tail structure that is divergent between the different classes of myosins (7) .
The myosin XV motor domain is predicted to contain ATPand actin-binding sites, which are followed by two myosin light chain-binding sites (IQ domains). Preceding the myosin XV motor domain is a large (1223 amino acids) proline-rich N-terminal extension, most of which is encoded by exon 2 (6) . Another myosin with an N-terminal extension of 266 amino acids is the class III myosin NinaC, which is found in the photoreceptor cells of Drosophila retinas (8) . The motor domain of NinaC is required for the structural integrity of the photoreceptor cells, whereas the N-terminal extension, a protein kinase domain, is involved in signal transduction. The myosin XV N-terminal extension, in contrast, is proline rich with no other predicted sequence similarity to reported proteins.
The myosin XV tail region contains five domains which are, in order from N-to C-terminal: a MyTH4 (myosin tail homology four) domain, a FERM-like domain, an SH3 (src homology 3) domain, a second MyTH4 domain and, finally, a FERM domain (6) . SH3 domains are protein modules that recognize and bind proline-rich sequences (9) and have been described in proteins that are involved in such functions as synaptic vesicle endocytosis (10) and proper subcellular localization of proteins (11) . FERM domains are found in a group of homologous proteins that include the band 4.1 superfamily (F, ezrin, radixin and moesin) (12) . Proteins with FERM domains interact with the cytoplasmic domains of integral membrane proteins such as CD44, CD43 and ICAM-2 and may function as cross-links between the cell membrane and the actin cytoskeleton (13) . MyTH4 domains are found in the tails of myosins IV, VIIA, X and XII (14) and at present their functions are unknown. Myosin VIIA contains two FERM domains, two MyTH4 domains and an SH3 domain (14, 15) organized in the same order as in myosin XV (6) . The similarity between the myosin XV and myosin VIIA tails is interesting because these unconventional myosins are both involved in hereditary hearing loss in humans and required for the proper structure and organization of the stereocilia in the organ of Corti (3, 16, 17) .
Mutations in Myo15 were discovered in sh2 mice and in three human kindreds with DFNB3 (18), implicating several regions of the protein as critical for proper function. Of the three mutations described in humans, two cause amino acid substitutions in the first MyTH4 domain and the third creates a premature stop codon that truncates the tail region (6) . The sh2 mutation is a substitution of a tyrosine residue for a cysteine in a highly conserved position of the myosin XV motor domain (3) . Another spontaneous allele, shaker 2 J (sh2 J ) (19) , also results in congenital deafness and vestibular defects. We report the characterization of the sh2 J mutation at the genomic and cellular level. This allele demonstrates the critical importance of the FERM domain in myosin XV function in both the auditory and vestibular systems. We also describe the developmental profile of Myo15 expression and show that Myo15 is expressed in the inner hair cells (IHCs) and outer hair cells (OHCs) of the post-natal cochlea.
RESULTS

Developmental expression of Myo15 mRNA
To determine the temporal and spatial expression of Myo15 during normal development of the mouse inner ear, a Myo15 riboprobe specific for exons 48-51 (Tail 1) was hybridized in situ to paraffin-embedded sections from C57BL/6J mouse embryos of different developmental stages (Fig. 1) . Myo15 transcripts were first detected at 13.5 days post-coitum (d.p.c.). No Myo15 transcripts were observed in the developing inner ear at either 11.5 or 12.5 d.p.c. (data not shown). Myo15 transcripts were restricted to discrete regions of the three cristae ampularis, macula utriculi and macula sacculi and the cochlea from 15.5 d.p.c. onward. The hybridization signal in 18.5 d.p.c. cochlea is restricted to the sensory epithelium of the organ of Corti. In situ hybridization of adjacent sections from these same embryos with a riboprobe specific for exon 2, the exon that encodes most of the N-terminal extension, demonstrated the same age of onset and restricted pattern of Myo15 expression as observed with the Tail 1 riboprobe (data not shown). Hybridization of post-natal day 8 (P8) mouse inner ears with the Tail 1 probe demonstrates that Myo15 mRNA is expressed in the IHCs and OHCs of the organ of Corti and is not detected in the surrounding supporting cells (Fig. 1) .
Abnormal stereocilia on hair cells in Myo15 sh2-J/sh2-J mice Scanning electron microscopy of cochleae from 1-month-old wild-type, Myo15 sh2-J/sh2-J and Myo15 sh2/sh2-J compound heterozygote mice shows that Myo15 sh2-J/sh2-J mice have very short stereocilia on both their IHCs and OHCs (Fig. 2) , much like those of the Myo15 sh2/sh2 mouse (3). The normal organizational pattern of the stereocilia is largely preserved although there are some ectopic stereocilia. A similar mutant phenotype is observed in Myo15 sh2/sh2-J compound heterozygotes, which indicates that the two alleles do not complement each other.
Laser scanning confocal microscopy of the rhodamineconjugated phalloidin-stained cochleae of 1-month-old Myo15 sh2-J/+ and Myo15 sh2-J/sh2-J mice detected long, actincontaining structures (referred to as 'cytocauds' in ref. 20) in the IHCs of Myo15 sh2-J/sh2-J animals but not in Myo15 sh2-J/+ animals ( Fig. 3C and D) . These structures, which can be as long as 50 µm, originate below the cuticular plate within each IHC of the cochlea and extend through the cell and outward from the base. Such structures were never observed in the OHCs. Hair cells in the vestibular epithelium were similarly abnormal. Epifluorescence analysis of whole-mount utricles labeled with rhodamine-conjugated phalloidin revealed long, well-organized stereocilia on wild-type utricular hair cells (Fig. 3E) . In contrast, very short stereocilia bundles were observed in the Myo15 sh2-J/sh2-J macula utriculi (Fig. 3F) . Elongated actin-containing structures, similar to those in the IHCs of the organ of Corti, were seen beneath the reticular lamina in most of the hair cells of the macula utriculi. Stereocilia in the sensory epithelium of the saccule and the three ampulae were short, similar to those in the utricle (data not shown). Based on the similarity between the sh2 and sh2 J phenotypes and their failure to complement, the defects in the sh2 J homozygous mice were presumed to be due to a mutation in Myo15.
The sh2 J allele is a deletion of part of Myo15
To identify the molecular defect in the sh2 J allele, Southern blots of HindIII-digested Myo15 sh2-J/sh2-J and Myo15 sh2-J/+ genomic DNA were hybridized with two probes located near the 3'-terminus of the gene (Fig. 4A and B) . Probe 1 (nucleotides 65 098-65 346, 248 bp, GenBank accession no. AF144093) hybridized to the same 6.2 kb restriction fragment from both region for the C-terminal FERM domain and the presumed 3' cleavage and polyadenylation signals from the mRNA. A 9 bp fragment was detected between the deletion break points (Fig.  4D) . Inspection of the sequence revealed that a 13 bp inverted repeat was created during the deletion process. Exons 2-59 of Myo15 from an sh2 J homozygote were also sequenced and no other mutations in the coding region were detected. 
Myo15 transcripts can be detected in
Myosin XV protein is present in inner ears of Myo15 sh2-J/sh2-J mice
To determine whether the abnormal Myo15 mRNA transcripts were translated, myosin XV protein expression was analyzed by immunofluorescence with anti-mouse myosin XV antibody (TF1) (6) directed against a region of the tail encoded 5' to the sh2 J deletion (Fig. 6 ). Whole-mount cochlear tissues from wild-type, Myo15 sh2/sh2 , Myo15 sh2-J/+ and Myo15 sh2-J/sh2-J adult animals were treated with TF1 antibody and a fluoresceinconjugated secondary antibody and then examined with a Fluorescence Microscopy Imaging System (CELLscan; Scanalitics, Fairfax, VA). Myosin XV expression was detected in the OHCs and IHCs. Labeling of the typical V-shaped groups of stereocilia on the three rows of OHCs is evident in the tissues of both wild-type mice and Myo15 sh2-J/+ heterozygotes (Fig. 6, column 1 ). This labeling is absent from the Myo15 sh2/sh2 and Myo15 sh2-J/sh2-J tissues, which is consistent with the developmental defect in the length of the stereocilia (Fig. 6, column 1) .
In the wild-type, immunofluorescence was also detected at the level of the actin-rich cuticular plate (Fig. 6, column 2) and below the level of the apical cell body (Fig. 6, column 3) . Myosin XV staining at the cuticular plate appears as a dispersed fluorescence in wild-type and Myo15 sh2-J/+ mice with some localized increase in staining corresponding to the rootlet of the kinocilium (Fig. 6 , column 2) in 4 of the 12 cochleae examined. This localized increase was not observed in the other 8 cochleae. The staining in both Myo15 sh2/sh2 and Myo15 sh2-J/sh2-J mice appears punctate and is more defined than the pattern observed in wild-type mice, which is suggestive of an altered intracellular distribution (Fig. 6, column 2 ). This punctate staining was observed in all 12 homozygous mutant cochleae examined (6 Myo15 sh2/sh2 and 6 Myo15 sh2-J/sh2-J ). Despite the deletion of 14.7 kb of genomic DNA, which includes the exons for the second FERM domain, the Myo15 sh2-J/sh2-J animals accumulate a presumably truncated form of myosin XV.
DISCUSSION
The shaker 2 and shaker 2 J mutant mice provide a model system for studying the molecular pathology of human hereditary non-syndromic deafness due to mutations at the DFNB3 locus (6). In wild-type mice, Myo15 transcripts are first detectable at ∼13.5 d.p.c. during the initial stages of hair cell maturation. The temporal and spatial expression of Myo15 appears to parallel the expression of Myo6 and Myo7A (21) , two other unconventional myosins that are mutated in mice with hearing loss and vestibular defects (22, 23) . Mutant alleles of the human ortholog MYO7A are associated with non-syndromic deafness DFNB2 and Usher syndrome type 1B (24) . Transcripts from Myo6 and Myo7A are first detected in the sensory epithelium of 13.5 d.p.c. otocysts and can be detected at high levels in the vestibular and cochlear sensory hair cells at 15.5 d.p.c. onward (21) . The similar temporal profiles of Myo6, Myo7A and Myo15 expression in hair cells suggests that they may be co-regulated.
The shaker 2 J mutation is a deletion of 14.7 kb of Myo15 genomic sequence that results in loss of the last six exons and a portion of the 3' flanking region. Despite the loss of the putative polyadenylation signal at position 76 103 (GenBank accession no. AF144093), stable Myo15 transcripts are synthesized and present in the correct spatial expression pattern in shaker 2 J mice. This indicates that essential transciptional regulatory elements are probably not located within the deletion region. Moreover, the abnormal Myo15 transcripts must utilize an alternative polyadenylation signal upstream of the deletion or a downstream sequence that was brought into proximity by the deletion. The abnormal Myo15 transcripts are translated since myosin XV protein is present in Myo15 sh2-J/sh2-J mice. In spite of the presence of the myosin XV protein the mice have profound congenital deafness and circling behavior. Thus, the mutant protein is not functional for either hearing or proper balance.
Humans homozygous for DFNB3 mutations have not been rigorously tested for vestibular function (18); however, deaf individuals from Bengkala, Indonesia, indicate that they feel 'inebriated' in the absence of visual cues (25) . This suggests that Myo15 may perform a similar role in the vestibular system in humans and mice and that it has a common role in the development and function of the sensory epithelia of both the vestibular system and the organ of Corti.
The effects of myosin XV defects on the cells of the inner ear were evaluated by microscopy of the organ of Corti and the vestibular sensory epithelia in shaker 2 and shaker 2 J mutants. Abnormally short stereocilia are present on the IHCs and OHCs of the organ of Corti and on hair cells of the utricular, saccular and ampullary epithelia in both mutants. In addition, the IHCs and vestibular hair cells of both mutants contain abnormal elongated structures with an actin core. Similar actin structures were first observed in the shaking-waltzing guinea pig (26, 27) .
The cellular phenotypes of the shaker 2 and shaker 2 J mice suggest that myosin XV has an important structural role in actin cytoskeleton organization. The stereocilia normally have a highly enriched actin content. In the presence of abnormal myosin XV, the stereocilia are very short and abnormal actin structures form, suggesting a failure in organization of the intracellular actin cytoskeleton. During development microvilli initially cover the apical surface of hair cells. The stereocilia are thought to develop by elongation of some microvilli whereas the remaining microvilli are eventually lost (28, 29) . The presence of short and ectopic stereocilia on the surface of the IHCs in shaker 2 and shaker 2 J mutants demonstrates that the normal development of stereocilia is disrupted when myosin XV function is altered by mutations. The characteristic three rows of V-shaped stereocilia groups develop on the OHCs of the mutants, which indicates that this aspect of OHC development is still present.
The shaker 2 and shaker 2 J mutant alleles have very different molecular lesions, yet they appear to produce the same phenotype. Myo15 sh2/sh2 , Myo15 sh2-J/sh2-J and Myo15 sh2/sh2-J animals display head tossing, circling, hyperactivity and deafness with no apparent differences in the cellular phenotypes in the vestibular system or the cochlea. The shaker 2 mutation affects the motor domain of myosin XV, whereas the shaker 2 J allele lacks the six exons that encode the C-terminal FERM domain of the myosin XV tail. FERM domains are found in membrane-associated proteins like moesin, radixin and talin that are involved in linking the cytoskeleton to the membrane (12) . The myosin XV C-terminal FERM domain may also play a role in anchoring the protein to the cell membrane. Deletion of the FERM domain may result in an inability to exert force on the actin cytoskeleton because the truncated protein is not anchored properly, causing a failure to form the scaffolding required for normal stereocilia structure. At this time it is unknown what proteins, other than actin, can bind to myosin XV or influence its function. The importance of a C-terminal FERM domain was suggested by a shaker 1 allele of Myo7A. The Myo7A 3336SB allele is a chemically induced mutation that introduces a premature stop codon, resulting in truncation of the C-terminal FERM domain and a severe deafness phenotype (15) . This mutation does not appear to affect the steady-state levels of mutant mRNA, much like the deletion of the FERM domain in Myo15 sh2-J/sh2-J mice. However, the protein levels in the Myo7A 3336SB mutants were only 13% that of wild-type. Results from these studies of Myo7A and our comparison of Myo15 sh2-J and Myo15 sh2 mutants support the hypothesis that the FERM domain is as critical for myosin function in the auditory system as the motor domain. Moreover, the protein partners that interact with the FERM domains of Myo7A and Myo15 are good candidates for genes involved in the development of normal hearing in mice and humans.
MATERIALS AND METHODS
Mice
Mice were obtained from the Jackson Laboratory (Bar Harbor, ME) and were cared for according to the National Institutes of Health Guidelines. Experiments were approved by the University of Michigan Committee on the Use and Care of Animals (protocol no. A3314-01), Laboratory of Molecular Genetics, NIH, NIDCD IUCAC (protocol no. 791-97) and Laboratory of Cellular Biology, NIH, NIDCD IUCAC (protocol no. 923-99). 
In situ hybridization
In situ hybridization was performed as described previously (30, 31) . Embryos from C57BL/6J mice were collected from timed pregnancies and staged according to Thieler (32) at 13.5, 15.5, 17.5 and 18.5 d.p.c. Embryos up to 15.5 d.p.c. were fixed intact in 4% paraformaldehyde in 1× phosphate-buffered saline (PBS). Animals at 17.5 d.p.c. and older were decapitated and only the heads were fixed. The skin and brain were removed from 18.5 d.p.c. and older heads prior to fixation. The tissues were embedded in paraffin and sectioned in the transverse orientation at a thickness of 10 µm.
Heads from a single litter produced by a Myo15 sh2-J/sh2-J × Myo15 sh2-J/+ mating were collected at P1, the skin and brains removed, the heads fixed in 4% paraformaldehyde in 1× PBS, embedded in paraffin and sectioned in the transverse orientation at a thickness of 12 µm. Genotyping was performed on tissue obtained at the time of dissection in order to identify animals heterozygous for the Myo15 sh2-J allele and the homozygous mutants. Riboprobes were designated Tail 1 (exons 48-51, nucleotides 8726-9199) and Tail 2 (exons 61-65, nucleotides 10212-10723) (GenBank accession no. AF144095). These cDNA fragments were subcloned into pGemT-easy (Promega, Madison, WI) and oriented so that both the sense and antisense riboprobes could be produced from the T7 RNA polymerase promoter. The riboprobes were double labeled with [α- 35 S]UTP and [α- 35 S]ATP using a Stratagene RNA transcription kit (catalog no. 200340; Stratagene, La Jolla, CA). Non-radioactive in situ hybridization of P8 mouse inner ears was performed on frozen sectioned tissue with digoxigenin-labeled Tail 1 probe as previously described (33) .
Southern blotting
Genomic DNA from the mouse strain on which shaker 2J arose, C57BL/Ks-db m, was obtained from the Jackson Laboratory. DNA from all other strains was prepared from lung, liver, kidney and spleen tissue and Southern blotting was performed as described (34) . Probe 1 (nucleotides 65098-65346, 248 bp) and Probe 2 (nucleotides 74210-74491, 282 bp) (GenBank accession no. AF144093) were amplified from genomic DNA by PCR (see Table 1 for primer sequences) and were used to serially hybridize a single Southern blot, which was stripped between hybridizations. The blot was washed in 0.1× SSC, 0.1% SDS at 57°C and exposed to a PhosphorImager screen (Molecular Dynamics, Sunnyvale, CA) for 1-2 days.
Genotyping
Four different oligonucleotide primers (primer 4, nucleotides 66972-66992; primer 5, nucleotides 67193-67213; primer 6, nucleotides 81653-81674; primer 7, nucleotides 81866-81883; GenBank accession no. AF144093) were designed for genotyping ( Table 1) . The primers were used in separate reactions in three combinations. Primers 4 and 5 amplify a 242 bp product which spans the 5' break point and primers 6 and 7 amplify a 231 bp product which spans the 3' break point. Primers 4 and 7 amplify a 185 bp product from the sh2 J allele, but do not result in a product from the wild-type allele because 14.7 kb is significantly longer than the PCR conditions allow. The PCR was carried out with 0.2 U of Taq polymerase (Roche Molecular Biochemicals, Indianapolis, IN) in a 25 µl reaction with the buffer supplied by the manufacturer, 0.2 mM dNTPs and 6 pmol each primer. Cycling conditions were: 92°C for 2 min; 30 cycles of 92°C for 30 s, 55°C for 30 s and 72°C for 30 s; 72°C for 10 min. Ten microliters of the reaction from each primer pair were pooled and electrophoresed on a 2% agarose, 1% NuSieve (FMC BioProducts, Rockland, ME), 0.5× TBE gel.
Sequencing
DNA from Myo15 sh2-J/sh2-J and C57BL6/J animals was amplified by PCR using primers designed within intron sequences 10-200 nucleotides from the intron-exon boundaries. The amplification products were separated by agarose gel electrophoresis and the appropriate bands were extracted, reamplified and purified by the Qiagen gel extraction method (Qiagen, Santa Clarita, CA). The purified products were sequenced on ABI 377 sequencer using one of the two PCR primers and analyzed using Sequencher software (Gene Codes, Ann Arbor, MI). Myo15 sequencing primers are available on request.
Scanning electron microscopy
Cochleae from 1-month-old Myo15 sh2-J/+ , Myo15 sh2-J/sh2-J and Myo15 sh2/sh2-J mice (n ≥ 2 each) were locally perfused with 2.5% glutaraldehyde in phosphate buffer (0.1 M) and dissected to reveal the surface of the organ of Corti epithelium. Samples were treated with 1% osmium tetroxide for 1 h, dehydrated in ethanol, critical point dried (Samdri 790; Tousimis, Rockville, MD), sputter coated with gold and viewed in an Amray 1000B scanning electron microscope operated at 10-15 kV.
Histochemistry and light microscopy
Cochleae from 1-month-old Myo15 sh2-J/+ , Myo15 sh2-J/sh2-J and Myo15 sh2/sh2-J mice were locally perfused with 4% paraformaldehyde (n ≥ 2 each). The overlying otic capsule was removed to allow penetration of reagents into the organ of Corti. The bone above the utricle and the ampulae was removed to expose the vestibular organs. Tissues were permeabilized in 0.3% Triton X-100 for 10 min, then incubated with rhodamine-phalloidin (1:100 dilution; Molecular Probes, Eugene, OR) as previously described (35) . Isolated segments of the organ of Corti were dissected free of surrounding tissues and mounted on glass microscope slides with Crystal Mount (Biomeda, Foster City, CA). Vestibular organs were removed from the bone as described previously (36) and mounted similarly to the cochlear samples. Preparations were examined and photographed using a Leica DMRB epifluorescence microscope using a 100× 1.3 numerical aperture objective. Samples analyzed with a confocal fluorescence microscope were prepared in a similar way. Analysis was performed using a Bio-Rad 600 confocal microscope (Bio-Rad, Hercules, CA) and a Z series of 1.0 µm thick optical sections was obtained, as described previously (37) .
Immunolocalization studies
Cochleae from 1-and 1.5-month-old B6C3F1/J, Myo15 sh2/sh2 , Myo15 sh2-J/sh2-J and Myo15 sh2-J/+ mice were perfused through the round and oval windows and a small fenestra in the apical cochlear bony capsule with 4% paraformaldehyde in PBS, pH 7.4, followed by incubation in this fixative for 1 h at room temperature (38) . Then cochleae were washed in 1× PBS and opened, and organs of Corti were dissected out of the modiolus using a fine needle. Samples were permeabilized with 0.5% Triton-X100 in 1× PBS for 30 min and washed in 1× PBS, followed by overnight incubation at 4°C in blocking solution (2% bovine serum albumin and 2% donkey serum in 1× PBS). Affinity-purified Myo15 antiserum TF1 (1.15 µg/µl) (6) was diluted 1:100 v/v in blocking solution and used in a 1 h room temperature incubation. After washing in 1× PBS, the tissue was incubated for 40 min using fluorescein-conjugated donkey anti-rabbit secondary antibody (Amersham, Arlington Heights, IL), diluted 1:200 v/v in blocking solution. After several washes in PBS, samples were mounted for microscopy with ProLong Antifade kit (Molecular Probes). Images were obtained using a Zeiss Axiophot microscope equipped with a 63× 1.4 numerical aperture objective, CCD camera (Photometric, Tuscon, AZ) and fluorescence microscopy imaging system (CELLscan). Control samples were treated as above but with omission of primary antibody or using preincubation of affinity-purified Myo15 antiserum (1.15 µg/µl) with a GSTMyo15 (amino acids 2157-2347; GenBank accession no. AF144094) fusion peptide (0.75 µg/µl) (6) in the proportions 1:1.6 w/w for 1 h at room temperature (data not shown).
